Real-time enrollment status for this thyroid eye disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06307626 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Thyroid Eye Disease |
| Phase | Clinical Trial |
| Target Enrollment | 123 participants |
| Active Locations | 11 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of March 2, 2026: Clinical trial NCT06307626 is currently active_not_recruiting participants. This clinical trial study for thyroid eye disease is not currently accepting new participants at 11 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06307626 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06307626 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.